Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools GIST

GIST

Programs, trials, and reported response and survival for gastrointestinal stromal tumor.

Data as of 11.07.2026

All studies

Imatinib

Imatinib Phase 2 (400 vs 600 mg)

Novartis · Phase 2 · Completed · Enrollment 147

Registry id n/r

ArmReported safety
Imatinib 400 mgn/r
Imatinib 600 mgn/r

A count stays a count. This page does not turn a count into a percent.